Technology
Health
Pharmaceutical

Hookipa Pharma Inc

$7.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.29 (4.15%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell HOOK and other stocks, options, ETFs, and crypto commission-free!

About HOOK

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. Read More The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.

Employees
56
Headquarters
New York, New York
Founded
2011
Market Cap
157.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
46.44K
High Today
$7.28
Low Today
$6.83
Open Price
$7.00
Volume
27.65K
52 Week High
$14.76
52 Week Low
$6.06

Collections

Technology
Health
Pharmaceutical
2019 IPO
US
North America

HOOK Earnings

-$0.63
-$0.59
-$0.55
-$0.51
Q2 2019
Estimated
-$0.51 per share
Actual
-$0.63 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.